Apolipoprotein E-derived peptides reduce CNS inflammation: implications for therapy of neurological disease
Authors:
- 1 August 2006
- journal article
- review article
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 114 (s185) , 15-20
Abstract
The apolipoprotein E4 isoform (apoE4) was initially identified as a susceptibility gene for the development of Alzheimer's disease, and has also recently been associated with poor outcome after acute traumatic and ischemic brain injury. One mechanism by which apoE may influence outcome in acute and chronic neurological disease is by downregulating glial activation and the neuroinflammatory response. Because it does not readily cross the blood-brain barrier (BBB), the apoE holoprotein has limited therapeutic potential. However, smaller peptides derived from the receptor binding region of apoE have been developed that mimic the functional anti-inflammatory and neuroprotective effects of the intact apoE protein. These apoE-derived therapeutic peptides cross the BBB and have been demonstrated to improve functional and histological outcomes in murine models of brain injury. Thus, the development of apoE-derived peptides represent a novel therapeutic strategy for the treatment of acute and chronic neurological disease.Keywords
This publication has 42 references indexed in Scilit:
- Two Apolipoprotein E Mimetic Peptides, ApoE(130−149) and ApoE(141−155)2, Bind to LRP1Biochemistry, 2004
- New Light on a Long‐Known Protein FamilyChemBioChem, 2003
- 813 Intracerebral Infusion of Human Recombinant Apolipoprotein E3 Reduces Global Ischemic Brain Injury in Apolipoprotein E Deficient MiceNeurosurgery, 2000
- Intraventricular Infusion of Apolipoprotein E Ameliorates Acute Neuronal Damage after Global Cerebral Ischemia in MiceJournal of Cerebral Blood Flow & Metabolism, 2000
- Apolipoprotein E Deficiency Worsens Outcome From Global Cerebral Ischemia in the MouseStroke, 1999
- The Apolipoprotein E ε4 Allele and Outcome in Cerebrovascular DiseaseStroke, 1998
- Incorporation of a Potentially Helix-Breaking D-Phe-Pro Sequence into the Center of a Right-Handed 16-Residue Peptide HelixBiochemical and Biophysical Research Communications, 1994
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993
- Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells.Proceedings of the National Academy of Sciences, 1992
- Oligodendrocytes but not astrocytes express apolipoprotein E after injury of rat optic nerveGlia, 1989